MedPath

Urinary Disorders in Patients With Multiple Sclerosis: Invasive Vs Non-invasive Investigations.

Not Applicable
Conditions
Urodynamics
Urinary Bladder, Neurogenic
Multiple Sclerosis
Registration Number
NCT03336424
Lead Sponsor
Saint-Joseph University
Brief Summary

The objective of the study is to describe the current status of MS patients with urinary disorders in Lebanon, and to demonstrate whether invasive investigations improve the management of these patients compared to an optimal non-invasive approach.

Detailed Description

All patients will be evaluated by an urologist, then randomized into 2 groups, the first group will benefit from non-invasive investigations and will be treated accordingly, the second group will benefit from an urodynamic assessment and will also be treated accordingly.

An evaluation will be made one month, 3 months and 6 months after the first visit.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • MS with urinary symptoms
Exclusion Criteria
  • BPH LUTS
  • Bladder cancer
  • prostate cancer
  • urethral stenosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
urinary symptoms6 months

filling and voiding urinary symptoms (UBQMS: Urinary Bothersome Questionnaire in Multiple Sclerosis), Voising Score Ranges from 0 to 3 ( 3 being most severe bother), Filling score ranges from 0 to 3 ( 3 being most severe bother).

urinary quality of life6 months

SF-QUALIVEEN: Short Form - health related quality of life questionnaire for urinary disorders in patients with neurological conditions. score ranges from 0 to 4 ( 4 being the worst quality of life).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saint Joseph University

🇱🇧

Beyrouth, Lebanon

Saint Joseph University
🇱🇧Beyrouth, Lebanon

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.